Wednesday’s rally took uCloudlink stock to its highest level since Aug. 7, 2023, and the upside came amid a volume spurt.
This move aligns with the company’s October guidance to target growth markets like AI, gallium nitride semiconductors, and memory devices.
The recent surge adds to the stock’s impressive gains of over 900% year-to-date.
The company posted loss per share of $0.27 versus the expected earnings per share of $0.06 quoted by Wall Street analysts.
Retail investors on Stocktwits are trolling short sellers for betting against Rigetti Computing’s quantum prowess.
Rigetti and Quantum Machines successfully automated the calibration of a 9-qubit Rigetti Novera quantum processing unit (QPU) using AI tools developed by Quantum Elements and Qruise.
Yext launched its expanded artificial intelligence Review Generation solution and the Yext Social AI-powered social media management solution.
Last month, Citi Trends announced its board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse as chairman.
The company said this move is part of a broader strategy to implement cost-cutting measures.
The Orphan Drug status provides CervoMed with several key benefits, including tax credits for clinical trial costs, regulatory assistance, and seven years of post-approval market exclusivity.